Jack Lin
Stock Analyst at Morgan Stanley
(0.94)
# 3,962
Out of 4,651 analysts
25
Total ratings
41.2%
Success rate
-4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Lin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCM HUTCHMED (China) | Upgraded: Hold | $14 → $14 | $12.20 | +11.48% | 3 | May 28, 2026 | |
| HKG: 0013 HUTCHMED (China) Limited | Maintained: Hold | $21.45 → $21.30 | $19.19 | +11.00% | 3 | May 28, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Upgraded: Buy | $19.60 → $17.00 | $14.94 | +13.79% | 3 | May 28, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $493.00 | $192.60 | +155.97% | 2 | Nov 20, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $215.00 | $96.00 | +123.96% | 3 | Nov 9, 2025 | |
| HKG: 9688 Zai Lab Limited | Maintained: Buy | $37.50 → $37.44 | $20.10 | +86.27% | 2 | Nov 6, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Hold | $89.00 | $80.70 | +10.29% | 2 | Oct 30, 2025 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $123.00 | $93.80 | +31.13% | 1 | Sep 22, 2025 | |
| HKG: 1952 Everest Medicines Limited | Maintained: Hold | $55.00 | $30.20 | +82.12% | 1 | Sep 22, 2025 | |
| HKG: 2162 Keymed Biosciences Inc. | Maintained: Buy | $93.50 | $78.15 | +19.64% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $48 | $25.90 | +85.33% | 3 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22.00 | $10.54 | +108.73% | 1 | Sep 19, 2025 |
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14 → $14
Current: $12.20
Upside: +11.48%
HUTCHMED (China) Limited
May 28, 2026
Maintained: Hold
Price Target: $21.45 → $21.30
Current: $19.19
Upside: +11.00%
InnoCare Pharma Limited
May 28, 2026
Upgraded: Buy
Price Target: $19.60 → $17.00
Current: $14.94
Upside: +13.79%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Maintained: Buy
Price Target: $493.00
Current: $192.60
Upside: +155.97%
Akeso, Inc.
Nov 9, 2025
Maintained: Buy
Price Target: $215.00
Current: $96.00
Upside: +123.96%
Zai Lab Limited
Nov 6, 2025
Maintained: Buy
Price Target: $37.50 → $37.44
Current: $20.10
Upside: +86.27%
RemeGen Co., Ltd.
Oct 30, 2025
Maintained: Hold
Price Target: $89.00
Current: $80.70
Upside: +10.29%
Innovent Biologics, Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $123.00
Current: $93.80
Upside: +31.13%
Everest Medicines Limited
Sep 22, 2025
Maintained: Hold
Price Target: $55.00
Current: $30.20
Upside: +82.12%
Keymed Biosciences Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $93.50
Current: $78.15
Upside: +19.64%
Sep 21, 2025
Maintained: Buy
Price Target: $50 → $48
Current: $25.90
Upside: +85.33%
Sep 19, 2025
Maintained: Buy
Price Target: $22.00
Current: $10.54
Upside: +108.73%